Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, published by Oxford University Press, is a leading peer-reviewed journal established in 1972, dedicated to advancing the field of epidemiology and its applications in medicine. With an impressive impact factor and a Q1 ranking in both Epidemiology and Miscellaneous Medicine, this journal ranks among the top-tier publications in its category, reflecting its commitment to high-quality research and scholarship. The journal serves as a vital platform for researchers, professionals, and students to share innovative findings, methodologies, and insights in epidemiological science, thus contributing to the broader understanding of public health. The journal includes a diverse range of articles encompassing the latest trends and developments in the field, ensuring comprehensive access to essential information and promoting evidence-based practices. For those seeking rigorous academic discourse and the latest research, the INTERNATIONAL JOURNAL OF EPIDEMIOLOGY is an indispensable resource in the realm of health studies.

EPIDEMIOLOGIC REVIEWS, an esteemed publication from Oxford University Press Inc, stands as a beacon in the fields of Epidemiology and Medicine, with a significant focus on synthesizing and analyzing the latest research and developments in these areas since its inception in 1979. This journal, with its ISSN 0193-936X and E-ISSN 1478-6729, is recognized for its high academic rigor, boasting a 2023 Q1 quartile ranking in both Epidemiology and Miscellaneous Medicine, and ranks #25 out of 148 in Scopus's Epidemiology category, placing it in the prestigious 83rd percentile. Although it does not currently offer open access, its subscription options provide comprehensive access to a wealth of epidemiological knowledge, essential for researchers, public health professionals, and students keen on advancing their understanding of health trends and disease patterns. With a commitment to promoting high-quality research and impactful insights, EPIDEMIOLOGIC REVIEWS plays a crucial role in enhancing public health discourse and shaping future epidemiological inquiries.

Health Security is a premier academic journal published by MARY ANN LIEBERT, INC, specializing in critical areas of public health, emergency medicine, and health policy. Since its inception in 2015, the journal has established itself as a vital resource for researchers, policymakers, and health professionals alike, boasting exceptional impact factors across multiple relevant categories, including Q1 in Emergency Medicine and Q1 in Safety Research. This esteemed publication not only contributes to the academic discourse surrounding health and safety but also offers open access options to maximize the dissemination of knowledge and innovative research. Health Security is dedicated to exploring the intersection of health, security, and safety, providing readers with timely and robust analysis that is particularly pertinent in today’s complex and evolving global health landscape. For those engaged in grassroots policy development or frontline emergency response, the journal stands as an indispensable tool for fostering understanding and facilitating informed action in an ever-changing environment.

REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES is a prestigious journal published by the OFFICE INTERNATIONAL DES EPIZOOTIES based in France, known globally for its commitment to advancing knowledge in the fields of Animal Science and Zoology as well as Medicine. With its ISSN 0253-1933 and E-ISSN 1608-0637, this journal has been a vital resource for researchers and practitioners since its establishment in 1990. Currently ranked in the Q3 quartile across both the Animal Science and Medicine categories in 2023, it reflects a growing impact in the veterinary community, holding commendable ranks in the veterinary general and miscellaneous categories. Although it does not offer open access options, its comprehensive articles are crucial for informing best practices, public health policies, and advancing research in veterinary medicine. With an emphasis on innovative approaches and evidence-based studies, the journal serves as a significant platform for networking and collaboration among scholars, professionals, and students dedicated to improving animal health and welfare worldwide.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.